We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+15.08%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$796M
AUM Growth
+$146M
(+22%)
Cap. Flow
+$82M
Cap. Flow
% of AUM
10.3%
Top 10 Holdings %
Top 10 Hldgs %
37.64%
Holding
72
New
23
Increased
22
Reduced
9
Closed
15
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
+$32.8M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$20.4M |
| 3 |
Incyte
INCY
|
+$19.5M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$18.9M |
| 5 |
AGN
Allergan Inc
AGN
|
+$18.8M |
Top Sells
| 1 |
Amgen
AMGN
|
+$38.7M |
| 2 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
+$28.8M |
| 3 |
STJ
St Jude Medical
STJ
|
+$25.8M |
| 4 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
+$23.3M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$23.3M |
Sector Composition
| 1 | Healthcare | 86.89% |
| 2 | Consumer Staples | 1.21% |
| 3 | Technology | 0.56% |
| 4 | Communication Services | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$165B
| $48.6M | 6.11% |
647,287
+117,487
| +22% | +$8.18M |
|
|
CLVS
2
DELISTED
Clovis Oncology, Inc.
CLVS
| $34.5M | 4.33% |
572,270
+100,925
| +21% | +$5.49M |
|
|
3
Zimmer Biomet
ZBH
$17.5B
| $34.3M | 4.3% |
+378,669
| New | +$32.8M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $30.9M | 3.88% |
366,036
+168,836
| +86% | +$13.4M |
|
5
AstraZeneca
AZN
$262B
| $30.3M | 3.81% |
511,120
+275,020
| +116% | +$14.9M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $28.9M | 3.63% |
172,240
-99,260
| -37% | -$15.5M |
|
7
Puma Biotechnology
PBYI
$426M
| $23.9M | 3% |
230,673
-109,492
| -32% | -$6.43M |
|
|
8
Jazz Pharmaceuticals
JAZZ
$15.1B
| $23.1M | 2.9% |
+182,561
| New | +$18.9M |
|
|
9
Incyte
INCY
$23B
| $22.7M | 2.86% |
+448,998
| New | +$19.5M |
|
|
ARRY
10
DELISTED
Array Biopharma Inc
ARRY
| $22.3M | 2.81% |
4,460,688
+791,095
| +22% | +$4.31M |
|
|
AGN
11
DELISTED
Allergan Inc
AGN
| $22.2M | 2.79% |
199,727
+197,100
| +7,503% | +$18.8M |
|
12
Globus Medical
GMED
$10.6B
| $21.9M | 2.75% |
1,086,637
+350,537
| +48% | +$6.51M |
|
|
13
Bristol-Myers Squibb
BMY
$119B
| $21.3M | 2.68% |
+400,870
| New | +$20.4M |
|
|
HTWR
14
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $20.9M | 2.62% |
222,023
+36,898
| +20% | +$3.12M |
|
|
KYTH
15
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $20.8M | 2.61% |
557,761
+329,543
| +144% | +$13.7M |
|
|
FOLD
16
DELISTED
Amicus Therapeutics
FOLD
| $20.3M | 2.55% |
8,648,087
+6,174,300
| +250% | +$13.6M |
|
17
HCA Healthcare
HCA
$83.8B
| $20M | 2.51% |
419,100
+4,700
| +1% | +$217K |
|
18
Tenet Healthcare
THC
$16.6B
| $19.4M | 2.44% |
461,402
-129,598
| -22% | -$5.64M |
|
|
OXFD
19
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $18.3M | 2.3% |
+946,457
| New | +$16.7M |
|
|
ICPT
20
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $18.2M | 2.28% |
+265,949
| New | +$15.4M |
|
|
RCPT
21
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $18.1M | 2.28% |
625,133
+604,333
| +2,905% | +$16.2M |
|
|
NUVA
22
DELISTED
NuVasive, Inc.
NUVA
| $17.8M | 2.24% |
550,914
-142,478
| -21% | -$4.28M |
|
23
Universal Health Services
UHS
$8.97B
| $16.7M | 2.1% |
+205,300
| New | +$16.4M |
|
24
Pfizer
PFE
$141B
| $16.4M | 2.06% |
+564,944
| New | +$16.4M |
|
25
Accuray
ARAY
$32.8M
| $15.2M | 1.91% |
1,744,811
+671,012
| +62% | +$5.21M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO